市場調查報告書
商品編碼
1399613
臨床試驗影像市場規模 - 按服務(臨床試驗設計和諮詢服務)、影像技術、治療領域、最終用戶、2023-2032 年全球預測Clinical Trial Imaging Market Size - By Service (Clinical Trial Design & Consultation Services), Imaging Technique, Therapeutic Area, End-user, Global Forecast 2023-2032 |
在全球生物製藥產業不斷擴張的推動下,臨床試驗影像市場規模預計從 2023 年到 2032 年將以 7.9% 的CAGR成長。從事新療法開發的生物製藥公司越來越依賴先進的影像服務來評估藥物的療效和安全性。隨著生物製藥公司對精準醫療和標靶治療的日益關注,臨床試驗中對強大且專業的影像解決方案的需求不斷增加。
此外,主要參與者正在投資尖端解決方案,包括用於影像解釋的人工智慧應用程式,以滿足對精確和即時資料日益成長的需求,同時吸引尋求最先進成像服務的贊助商和研究人員,進一步加速產業擴張。例如,2023 年 3 月,Clario 推出了一款基於雲端的影像檢視器應用程式,供申辦者和合約研究組織 (CRO) 檢查臨床試驗影像。
整個產業分為服務、影像技術、治療領域、最終用戶和地區。
從服務來看,臨床試驗設計和諮詢服務市場在 2022 年獲得了巨大的吸引力,預計 2023 年至 2032 年期間將實現 8.7% 的成長率。臨床試驗設計和諮詢服務見證了對規劃成像方案的高需求,以確保法規遵循和最佳化試驗效率。隨著製藥和生物技術公司越來越認知到成像終點在臨床試驗中的重要性,對專業設計和諮詢服務的需求也不斷成長。
就最終用戶而言,醫療器材製造商領域的臨床試驗影像市場預計從 2023 年到 2032 年將以 7.3% 的CAGR成長。醫療器材製造商擴大將影像技術涵蓋臨床試驗,以評估產品的功效和安全性。此外,醫療設備製造商和臨床試驗影像服務提供者之間持續合作,在遵守法規的同時促進精確的資料收集和分析,將有助於該細分市場的成長。
從地區來看,由於臨床研究活動的增加和對醫療保健創新的日益重視,亞太地區臨床試驗影像產業預計在 2023 年至 2032 年間呈現 8.8% 的CAGR。該地區患者群體多樣化以及具有成本效益的臨床試驗解決方案的可用性更高,正在吸引跨國製藥公司的投資。一些市場參與者也採取措施,幫助公共醫療機構成為卓越的臨床研究中心,以提升價值鏈,擴大區域產業前景。例如,2023年10月,羅氏製藥印度公司在印度啟動了卓越臨床試驗計劃,幫助印度公共衛生機構進行臨床試驗和藥物研究。
Clinical Trial Imaging Market size is projected to expand at 7.9% CAGR from 2023-2032 driven by the expanding biopharmaceutical sector across the globe. Biopharmaceutical companies, engaged in the development of novel therapies, increasingly rely on advanced imaging services to assess drug efficacy and safety. With the growing focus of the biopharma companies on precision medicine and targeted therapies, the demand for robust and specialized imaging solutions in clinical trials is rising.
Furthermore, key players are investing in cutting-edge solutions, including AI applications for image interpretation for catering to the increasing demand for precise and real-time data, whilst attracting sponsors and researchers seeking state-of-the-art imaging services, further accelerating the industry expansion. For instance, in March 2023, Clario launched a cloud-based Image Viewer application for sponsors and contract research organizations (CROs) to examine clinical trial images.
The overall industry is segmented into service, imaging technique, therapeutic area, end user, and region.
As per service, the clinical trial design & consultation services market gained significant traction in 2022 and is anticipated to depict 8.7% growth rate during 2023-2032. Clinical trial design and consultation services are witnessing high demand for planning imaging protocols for ensuring regulatory compliance and optimizing trial efficiency. With pharmaceutical and biotechnology companies increasingly recognizing the importance of imaging endpoints in clinical trials, the demand for specialized design and consultation services is also rising.
In terms of end-user, the clinical trial imaging market from the medical devices manufacturers segment is estimated to expand at 7.3% CAGR from 2023 to 2032. Medical device manufacturers are increasingly incorporating imaging technologies in clinical trials to assess product efficacy and safety. Additionally, the ongoing collaboration between medical device manufacturers and clinical trial imaging service providers for facilitating precise data acquisition and analysis while complying with regulations will contribute to the segment growth.
Regionally, the Asia Pacific clinical trial imaging industry is set to exhibit 8.8% CAGR between 2023 and 2032 attributed to the increasing clinical research activities and the growing emphasis on healthcare innovation. The presence of diverse patient population and the higher availability of cost-effective clinical trial solutions in the region are attracting investments from multinational pharmaceutical companies. Several market participants are also taking steps to help public healthcare facilities become clinical research centers of excellence for ascending the value chain, augmenting the regional industry outlook. For instance, in October 2023, Roche Pharma India commenced its clinical trial excellence initiative in India to help public health institutions in the nation conduct clinical trials and drug research.